Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04307940 · ClinicalTrials.gov registry record · Phase 4
Study to Collect Information on How Well the Study Drug Naproxen Sodium Tablets Works Compared to Hydrocodone/Acetaminophen Tablets in Order to Relieve Pain in Participants Experiencing Moderate to Severe Pain After Having Their Wisdom Teeth Removed
A Phase 4 study, sponsored by Bayer.
- Completed
- Registry status
- Phase 4
- Development phase
- 221
- Enrollment target
NCT04307940 is a Phase 4 study that has completed, run by Bayer. The registered enrollment target is 221 participants.
The verdict
NCT04307940, a Phase 4 study, has completed, sponsored by Bayer.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 221 participants
- Enrollment target
Study Summary
With this study researchers want to collect information on how long the pain relief lasts after a fixed dose of naproxen sodium or hydrocodone/acetaminophen or placebo (contains no medication) over 12 hours in subjects experiencing moderate to severe pain after having their wisdom teeth removed. Naproxen Sodium (Aleve®) is a drug that is used for the temporary relief of minor aches and pains. Hydrocodone/Acetaminophen is a combination drug used to relieve moderate to severe pain. It contains an opioid (narcotic) pain reliever (hydrocodone) and a non-opioid pain reliever (acetaminophen).
Interventions
- DRUG Placebo
- DRUG Naproxen Sodium (Aleve, BAY117031)
- DRUG Hydrocodone/Acetaminophen
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 221 participants |
| Start Date | 2020-03-12 |
| Est. Completion | 2020-10-05 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04307940
The ClinicalTrials.gov registry entry for NCT04307940 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 221 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Bayer, which has 591 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which Placebo is the first listed.
NCT04307940 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04307940 about?
NCT04307940 is a clinical study titled "Study to Collect Information on How Well the Study Drug Naproxen Sodium Tablets Works Compared to Hydrocodone/Acetaminophen Tablets in Order to Relieve Pain in Participants Experiencing Moderate to Severe Pain After Having Their Wisdom Teeth Removed". With this study researchers want to collect information on how long the pain relief lasts after a fixed dose of naproxen sodium or hydrocodone/acetaminophen or placebo (contains no medication) over 12 hours in subjects experiencing moderate to severe pain after having their wisdom teeth removed. Nap...
What is the current status of trial NCT04307940?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 221 participants. The study started on 2020-03-12. Estimated completion is 2020-10-05.
What interventions are being tested in trial NCT04307940?
The interventions under investigation include: Placebo (DRUG), Naproxen Sodium (Aleve, BAY117031) (DRUG), Hydrocodone/Acetaminophen (DRUG).
Who is sponsoring clinical trial NCT04307940?
This trial is sponsored by Bayer, which has 591 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.